John C. McKew
2023
In 2023, John C. McKew earned a total compensation of $904.8K as President and Chief Scientific Officer at NewLink Genetics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $287,425 |
|---|---|
| Option Awards | $37,369 |
| Salary | $535,500 |
| Stock Awards | $7,040 |
| Other | $37,457 |
| Total | $904,791 |
McKew received $535.5K in salary, accounting for 59% of the total pay in 2023.
McKew also received $287.4K in non-equity incentive plan, $37.4K in option awards, $7K in stock awards and $37.5K in other compensation.
Rankings
In 2023, John C. McKew's compensation ranked 1,321st out of 2,978 executives tracked by ExecPay. In other words, McKew earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,321 out of 2,978 | 56th |
Division Manufacturing | 792 out of 1,637 | 52nd |
Major group Chemicals And Allied Products | 524 out of 906 | 42nd |
Industry group Drugs | 511 out of 869 | 41st |
Industry Pharmaceutical Preparations | 355 out of 627 | 43rd |
Source: SEC filing on April 12, 2024.
McKew's colleagues
We found two more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2023.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020